1. Home
  2. EYPT vs VBNK Comparison

EYPT vs VBNK Comparison

Compare EYPT & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • VBNK
  • Stock Information
  • Founded
  • EYPT 1987
  • VBNK 1980
  • Country
  • EYPT United States
  • VBNK Canada
  • Employees
  • EYPT N/A
  • VBNK N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • VBNK Commercial Banks
  • Sector
  • EYPT Industrials
  • VBNK Finance
  • Exchange
  • EYPT Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • EYPT 427.9M
  • VBNK 441.5M
  • IPO Year
  • EYPT 2005
  • VBNK 2021
  • Fundamental
  • Price
  • EYPT $6.51
  • VBNK $11.02
  • Analyst Decision
  • EYPT Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • EYPT 8
  • VBNK 3
  • Target Price
  • EYPT $25.71
  • VBNK $19.00
  • AVG Volume (30 Days)
  • EYPT 841.5K
  • VBNK 91.7K
  • Earning Date
  • EYPT 05-07-2025
  • VBNK 06-04-2025
  • Dividend Yield
  • EYPT N/A
  • VBNK 0.65%
  • EPS Growth
  • EYPT N/A
  • VBNK N/A
  • EPS
  • EYPT N/A
  • VBNK 0.89
  • Revenue
  • EYPT $43,273,000.00
  • VBNK $75,813,751.00
  • Revenue This Year
  • EYPT N/A
  • VBNK $31.26
  • Revenue Next Year
  • EYPT N/A
  • VBNK $40.97
  • P/E Ratio
  • EYPT N/A
  • VBNK $14.82
  • Revenue Growth
  • EYPT N/A
  • VBNK N/A
  • 52 Week Low
  • EYPT $3.91
  • VBNK $8.51
  • 52 Week High
  • EYPT $21.26
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.19
  • VBNK 57.71
  • Support Level
  • EYPT $5.37
  • VBNK $9.59
  • Resistance Level
  • EYPT $5.86
  • VBNK $11.33
  • Average True Range (ATR)
  • EYPT 0.57
  • VBNK 0.63
  • MACD
  • EYPT 0.20
  • VBNK 0.27
  • Stochastic Oscillator
  • EYPT 99.81
  • VBNK 89.04

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: